DNAe
PrivateLast Round
Grant
Sep 30, 2016
Total Funding Raised
$113.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
DNAe operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Grant round in September 2016.
DNAe is a biotechnology company that develops a semiconductor-based, point-of-need next-generation sequencing platform for rapid infectious disease and oncology diagnostics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
DNAe Comparables
Compare DNAe with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GenomeKey | 81% | |
| HelixBind | 80% | |
| Scanogen Inc. | 78% |
For institutional investors. Book with your work email.
DNAe Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 30, 2016 | ||||
| Debt | Nov 2, 2015 | ||||
| Corporate Funding | Jan 15, 2015 | ||||
| Early Funding | Apr 27, 2014 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
DNAe Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Public Health Emergency Medical Countermeasures Enterprise | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 114% MoM, reaching 1.7K.
- Apr 16, 2026
Monthly visitors increased 31% MoM, from 6.2K to 8.2K.
For institutional investors. Book with your work email.
DNAe Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about DNAe's valuation, stock price, and market status.
Is DNAe a public or private company?
DNAe is a private company.
What is the current stock price of DNAe?
DNAe is a private company, so its shares have no public market price. Caplight tracks DNAe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is DNAe worth (valuation)?
Valuation information for DNAe is not publicly available.
Can I buy DNAe stock?
DNAe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was DNAe's last funding round?
DNAe's most recent funding round was Grant on September 30, 2016.
Who are the main investors in DNAe?
Key investors in DNAe include Public Health Emergency Medical Countermeasures Enterprise.
Will DNAe IPO soon?
No public IPO plans have been announced for DNAe.
How can I track DNAe secondary market activity?
Caplight tracks bids, offers, and trades in DNAe's shares on secondary markets.